SUNLOCPharmaceuticals

Sunil Healthcare LtdQuarterly Results & Earnings

61.97
-3.68%
Profit Growth YoY281.82%Latest quarter
Sales Growth YoY16.09%Latest quarter
Sales CAGR 5Y3.56%5 year compound
Profit CAGR 5Y11.44%5 year compound
📋

Quarterly Performance

YoY Profit Growth+281.82%
🔥 Exceptional growth
YoY Sales Growth+16.09%
✅ Strong growth
OPM 5Y Average
Operating profit margin
10.84%
EPS Growth 5Y
11.44%
Interest Coverage
Higher = safer debt servicing
1.36
ROE
-1.95%
ROCE
3.96%
💡

Growth Analysis

Sunil Healthcare Ltd reported YoY profit growth of 281.82% and revenue growth of 16.09% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 3.56% and profits at 11.44% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.